|
Market Closed -
Nasdaq
16:00:00 2026-10-14 EDT
|
5-day change | 1st Jan Change | ||
| 24.77 USD | -1.20% |
|
-6.63% | -5.92% |
| 09-14 | Zymeworks Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-14-2026 04:50 PM | |
| 08-26 | U.S. research roundup- Intuit, MongoDB, Zscaler | RE |
| Market Cap | 1.78B 1.6B 1.49B 1.35B 2.54B 169B 2.56B 17.91B 6.99B 87.86B 6.68B 6.53B 283B | P/E 2026 * |
28.1x | P/E 2027 * | 28.5x |
|---|---|---|---|---|---|
| Enterprise Value | 1.78B 1.6B 1.49B 1.35B 2.54B 169B 2.56B 17.91B 6.99B 87.86B 6.68B 6.53B 283B | EV / Sales 2026 * |
6.14x | EV / Sales 2027 * | 4.55x |
| Free-Float |
92.05% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ZYME | Delayed | |
CBOE
| ZYME | Real-time | |
|
Tradegate
| ZA8 | Real-time | |
|
Deutsche Boerse AG
| ZA8 | Delayed | |
|
Börse Stuttgart
| ZA8 | Delayed | |
|
Boerse Muenchen
| ZA8 | Real-time |
Last Transcript: Zymeworks Inc.
| 1 day | -1.20% | ||
| 1 week | -6.63% | ||
| Current month | -6.49% | ||
| 1 month | -7.75% | ||
| 3 months | +0.45% | ||
| 6 months | -8.19% | ||
| Current year | -5.92% |
| 1 week | 24.6 |  | 26.34 |
| 1 month | 24.6 | | 28.26 |
| Current year | 21.52 | | 31.34 |
| 1 year | 16 | | 31.34 |
| 3 years | 6.46 | | 31.34 |
| 5 years | 4.11 | | 31.34 |
| 10 years | 4.11 | | 59.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ken Galbraith
CEO | Chief Executive Officer | 63 | 2022-01-04 |
Kristin Stafford
DFI | Director of Finance/CFO | 44 | 2026-03-31 |
Adam Schayowitz
CTO | Chief Tech/Sci/R&D Officer | - | 2026-04-08 |
| Director | Title | Age | Since |
|---|---|---|---|
Ken Galbraith
CHM | Chairman | 63 | 2022-01-04 |
Susan Mahony
BRD | Director/Board Member | 61 | 2019-05-31 |
Kelvin Neu
BRD | Director/Board Member | 52 | 2020-02-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/9/26 | Exercice | Chief Technology Officer | 87,906 | 0.1239% | ||
| 7/6/26 | Free | Chief Operating Officer | 939 | 0.0013% | ||
| 5/13/26 | Free | EVP, General Counsel | 297,000 | 0.4027% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.20% | -6.63% | +35.87% | +251.35% | 1.78B | |
| -2.01% | -7.86% | +54.60% | +70.97% | 70.44B | |
| +3.84% | -10.61% | +6.97% | +57.43% | 50.31B | |
| +3.35% | +1.60% | +10.58% | +40.01% | 47.51B | |
| +0.51% | +1.51% | +27.96% | +31.68% | 42.91B | |
| +2.70% | -3.66% | +307.41% | +467.17% | 40.39B | |
| +0.69% | -3.44% | +9.52% | +102.07% | 39.69B | |
| +0.06% | -1.43% | +10.47% | +43.27% | 30.59B | |
| -2.95% | -14.09% | +37.94% | +1.30% | 26.8B | |
| -0.39% | -6.92% | -13.60% | -8.57% | 22.36B | |
| Average | +0.61% | -5.25% | +48.77% | +105.67% | 37.28B | |
| Weighted average by Cap. | +0.93% | -5.42% | +53.09% | +95.72% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 290M 260M 243M 220M 413M 27.55B 416M 2.92B 1.14B 14.3B 1.09B 1.06B 45.99B | 391M 352M 328M 297M 558M 37.21B 562M 3.94B 1.54B 19.31B 1.47B 1.44B 62.12B |
| Net income | 57.18M 51.41M 47.97M 43.48M 81.63M 5.44B 82.14M 576M 225M 2.82B 215M 210M 9.08B | 129M 116M 108M 98.01M 184M 12.27B 185M 1.3B 507M 6.37B 484M 473M 20.47B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-14 | US$24.77 | -1.20% | 556,570 |
| 26-10-13 | US$25.07 | -1.03% | 2,455,340 |
| 26-10-12 | US$25.33 | -1.78% | 2,775,789 |
| 26-10-09 | US$25.79 | +2.10% | 491,135 |
| 26-10-08 | US$25.26 | -4.79% | 1,367,159 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ZYME Stock
Select your edition
All financial news and data tailored to specific country editions
